Clinical trial

Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients

NCT05016219

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2023-08-22

PhaseNA

Study timeline

Study start (actual)2023-08-22Date precision: day

Registry last updated2026-05-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Mild Cognitive Impairmentunresolved

Interventions

Circadian-Effective LightDEVICE

Rhythmic LightDEVICE

Placebo LightDEVICE

Placebo Rhythmic LightDEVICE

Sponsors & collaborators

Icahn School of Medicine at Mount Sinailead sponsor

Mapped research locations

New YorkNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05016219 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.